February 26, 2021
New data from an observational study provide some support for antiplatelet therapy in patients with moyamoya disease, a rare arteriopathy characterized by progressive stenosis of the distal internal carotid artery and other basal cerebral arteries.
Patients with moyamoya disease prescribed antiplatelet therapy, tracked through the Korean National Health Insurance Service (NHIS) database, had a significantly lower risk of death than those who didn’t receive antiplatelet therapy (HR 0.77; 95% CI 0.70-0.84). The largest reduction in mortality was seen in patients who were prescribed the phosphodiesterase inhibitor cilostazol (HR 0.57; 95% CI 0.49-0.68).
Based on their findings, “antiplatelet therapy generally, and cilostazol particularly, shows observational evidence of potential benefit as medical treatment for patients with moyamoya disease,” write Woo-Keun Seo, MD, PhD (Samsung Medical Center, Seoul, South Korea), and colleagues in their study published Feb
Anemia linked to abnormal mobility capacity in elderly, finds study medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.
Dec 10, 2020
We investigated the cardiovascular complications and mortality rates of patients with diabetes in South Korea. The rates of hospitalization due to cardiovascular complications and mortality were analyzed using the Korean National Health Insurance Service-National Sample Cohort. From 2006 to 2015, the rates of hospitalization due to major cardiovascular complications decreased, while those due to heart failure (from 72 to 146 and 124 to 161 per 10,000 men and women, respectively) and peripheral artery disease (from 39 to 55 and 19 to 35 per 10,000 men and women, respectively) increased. In the period 2007 to 2015, the mortality rates for cancer, cerebrovascular disease, diabetes, heart disease, and hypertensive disease all decreased. However, the mortality rate for pneumonia increased. We observed a continuous reduction in cardiovascular complications and mortality in adults with diabetes. However, with the increase in some diabetes complications, more efforts are needed